ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis
Clinical trial NCT03093259 · COMPLETED
Trial details
- NCT number
- NCT03093259
- Sponsor
- Abivax S.A.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-16
- Primary completion
- 2018-07-25
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.